FDA Enquires Into New Chantix Side-Effects
Date: 5th June 2009
According to a latest disclosure, the FDA (Food and Drugs Administration) is gearing up to examine and analyze new side-effects yielded by the anti-smoking medicine Chantix and the potential Chantix side-effects being probed by FDA are adverse skin reactions, risk of angiodema, accidental injury and visual difficulty. Altogether, sources make it apparent that chantix, the Pfizer manufactured anti-smoking drug, was included in a report released recently by the FDA on medicines, the agency was investigating to evaluate powerful signals of new drug risks.
Pertaining to the latest safety issues identified by the FDA, it has been known that specific skin reactions, namely, Stevens-Johnson syndrome in which burning occurs in the skin from inside out, has been found to result from Chantix usage. Stevens-Johnson syndrome puts life at risk by accelerating blindness, organ failure as well as disfigurement and the news related to Stevens-Johnson syndrome triggered off by Chantix first appeared in an independent report published by the “Institute for Safe Medicine Practices”. It is also known that the report from “Institute for Safe Medicine Practices” recognized the possible risk of accidents from Chantix which is now being reviewed by the FDA.
Further, regarding accidental injury from Chantix, it is known that the FDA has received several reports on accidents faced by Chantix users that are capable of affecting an individual’s alertness or motor control. With regard to angiodema, FDA states that it is a swelling occurring under the skin and is capable of causing airway obstruction as well as suffocation.
However, the FDA clarifies that inquiry of chantix-related safety issues by the agency doesn’t state that there is a specific relationship between the identified risks and chantix side-effects. To add on, the FDA states that it is trying to analyze these latest Chantix side-effects to evaluate whether there is any necessity for stronger warning or any other form of restrictive action.
Source: http://www.aboutlawsuits.com/ |
